With the main-technology troponin assays, about 33% of individuals presenting with indicators of acute coronary syndromes were being discovered to get elevated troponin stages during the absence of elevated CK-MB concentrations.31 As assays have become more sensitive, an even better variety of patients happen to be identified with elevated troponin